⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8988246 | 0.73 | — | — | |
| SCHEMBL13875825 | 0.73 | — | — | |
| SCHEMBL10960949 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL10420594 | 0.71 | — | — | |
| Bromide SCHEMBL6578177 | 0.71 | — | — | |
| Water SCHEMBL2452742 | 0.71 | — | — | |
| Ammonia Solution, Strong SCHEMBL10420593 | 0.71 | — | — | |
| SCHEMBL11794601 | 0.70 | EPHX1 (0.32) | — | |
| SCHEMBL14414564 | 0.69 | — | — | |
| SCHEMBL3973408 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938236-B2 | Antiviral agents against HBV infection | DREXEL UNIVERSITY (US) | 2018-04-10 | — | — | US | disclosed |
| US-20160333135-A1 | CURABLE COMPOSITION | DAIKIN INDUSTRIES, LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-20160024004-A1 | NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
| US-20160009946-A1 | UNDER LAYER FILM-FORMING COMPOSITION FOR IMPRINTS AND METHOD FOR FORMING PATTERN | FUJIFILM CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-8865930-B2 | Method for making terpene derivatives | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140221361-A1 | C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2014-08-07 | — | — | US | disclosed |
| US-8158663-B2 | N-[2-thiazolylidene- or 2-oxazolylidene]carbo- or heterocyclecarboxyamides, e.g., 5-chloro-2-methoxy-N-[(2Z)-3-(2-methoxyethyl)-5,5-dimethyl-1,3-thiazolidin-2-ylidene]benzamide; treating neuropathic, nociceptive, and inflammatory pain and immune, respiratory, and cardiovascular disorders | ABBOTT LABORATORIES (US) | 2012-04-17 | — | — | US | disclosed |
| US-20110152563-A1 | METHOD FOR MAKING TERPENE DERIVATIVES | SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2011-06-23 | — | — | US | disclosed |
| US-20110152563-A1 | METHOD FOR MAKING TERPENE DERIVATIVES | SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2011-06-23 | — | — | US | disclosed |
| WO-2008079687-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2008-07-03 | — | — | WO | disclosed |
| US-20080153883-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2008-06-26 | — | — | US | disclosed |